Tech Company Financing Transactions
Midas Healthcare Funding Round
Midas Healthcare closed a $2 million Series A investment round on 10/26/2023. Backers included MCPC Healthcare Investment.
Transaction Overview
Company Name
Announced On
10/26/2023
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for expansion of its product development efforts in preparation for the 2024 product rollout.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
99 Wall St 360
New York, NY 10005
USA
New York, NY 10005
USA
Phone
Undisclosed
Website
Email Address
Overview
MIDAS was formed in 2017 to address failures in medication security, enabling rising levels of diversion of controlled substances. This is one of the main factors fueling the nation's opioid epidemic. The genesis for MIDAS was Founder and CEO Michael LaFauci's vision to safely neutralize and dispose of Fentanyl patches. Knowing that these patches are widely prescribed with no safe means of disposal, he created the Patch Catcher� in an effort to reduce accidental exposure to the discarded medication. This idea sparked a conversation about medication security across all areas of healthcare. From this realization, the MIDAS team was assembled to create solutions to these glaring concerns.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Lafauci
Chief Operating Officer
Jonathan Pinsky
President
Jeffrey Wahl
Browse more venture capital transactions:
Prev: 10/26/2023: Faction venture capital transaction
Next: 10/26/2023: Omnidian venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs